Clinical Trial Update: Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating the combination of pucotenlimab and becotatug vedotin for advanced cutaneous squamous ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Becotatug Vedotin
• Pucotenlimab

Snippet

Sponsor: Fudan University | Conditions: Cutaneous Squamous Cell Carcinoma (CSCC) | Phase 2 | Status: NOT_YET_RECRUITING